Evidence-Based Diabetes Management
Carmella Sebastian, MD, MS, CPE; and Karla Logston, RN, BS, CDE
How does the largest payer in a state with a large senior population respond to the rising need for diabetes care and prevention?
Part 1: See Part 2 in the September issue of Evidence-Based Diabetes Management.
The author, who has lived with type 1 diabetes for more than 50 years, shares his account of a successful appeal of Medicare's policy of refusing to pay for continuous glucose monitoring (CGM.)
Jaime A. Davidson, MD, FACP, FACE; and Christopher Parkin, MS
A recent Diabetes Care study found flaws in Medicare's competitive bidding program for diabetes test strips. Two of that study's co-authors discuss the findings and why CMS should suspend the bidding program.
John J. Sheehan, PhD, RPh; and Joanna P. MacEwan, PhD
The authors discuss a simple strategy for payers to ensure more patients with type 2 diabetes achieve control of A1C.
Mike Payne, MBA, MSci
Now that Medicare is poised to pay for the Diabetes Prevention Program, the next question is how to make it scalable.
Kylee A. Funk, PharmD, BCPS; and Todd Sorensen, PharmD
Authors from the University of Minnesota College of Pharmacy highlight the role that pharmacists can play in care optimization for seniors with chronic conditions.
Bernadette Melnyk, PhD, RN, CPNP/PMHNP, FNAP, FAAN
When providers move from employing traditional practices to new methods that are steeped in evidence, this benefits patient health. The result is higher-quality, more affordable care, often stemming from lower rates of hospital infections, readmissions, and, in general, improved outcomes.
Trishan Panch, MD, MPH; and Elaine Goodman, MD, MBA
As primary care physicians and leaders of Wellframe—a mobile health company working with payers and physicians groups to extend care between visits for patients with complex comorbidities—Drs Panch and Goodman discuss their experiences building a mobile application used by elderly patients to communicate with clinicians and manage chronic disease.
The earliest studies involving diabetes therapy for Alzheimer’s are recruiting patients.
Training seniors to manage their own diabetes takes many hands--most notably, those of the patients themselves. A look at how a diabetes management program serving a diverse population approaches this task.
The study highlights results from the population largely denied CGM coverage under Medicare.